Renal Cell Carcinoma

Episodes

Daniel J. George, MD, Duke University School of Medicine

July 7, 2023

Dr Daniel J. George Discusses the Use of Biomarkers in RCC Treatment

While there are reliable biomarkers to monitor disease progression and guide treatment decisions for tyrosine kinase inhibitors in renal cell carcinoma (RCC), there is a need for biomarkers for immunotherapies.

June 22, 2023

Site of Metastasis Is Significant in Renal Cell Carcinoma, Dr Daniel George Explains

Where renal cell carcinoma spreads can have a significant impact on prognosis and treatment options for patients.

May 30, 2023

Dr Rana McKay on First-Line Therapies for Metastatic Renal Cell Carcinoma

By AJMC Staff

In this first part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, provides an overview of the treatment landscape for advanced renal cell carcinoma.

May 23, 2023

Dr Rana McKay on Second-Line Treatment Options for Advanced RCC

By AJMC Staff

In the second part of a 2-part series, Rana R. McKay, MD, associate professor of Medicine and Urology, Moores Cancer Center, University of California San Diego, discusses second-line treatment options for advanced renal cell carcinoma (RCC).

May 9, 2023

Dr Alan Tan on the Options for Patients With Advanced RCC

Survival is good for patients when renal cell carcinoma (RCC) is caught early, but options for advanced disease present challenges, explained Alan Tan, MD, an assistant professor in the Division of Hematology, Oncology and Cell Therapy at Rush Medical College and the director of GU Medical Oncology.

May 2, 2023

Dr Alan Tan Provides Overview of RCC Prevalence, Presentation, Diagnosis

Many times, renal cell carcinoma (RCC) is found incidentally, as a result of something else, said Alan Tan, MD, an assistant professor in the Division of Hematology, Oncology and Cell Therapy at Rush Medical College and the director of GU Medical Oncology.